Company profile: Essential Pharma
1.1 - Company Overview
Company description
- Provider of new tools for medical researchers and manufacturers to bring performance, convenience, and control to the advancement of basic research and drug discovery, supporting the preservation and growth of human systems from the cell to the entire organ. Based in Ewing, NJ.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Essential Pharma
OrganOx
HQ: United Kingdom
Website
- Description: Provider of normothermic machine perfusion technology for donor livers via OrganOx metra, enabling functional assessment and preservation for up to 24 hours. Offerings support evaluation of liver function prior to transplantation, provide more flexible transplant logistics and surgery scheduling, and support complex or lengthy surgeries by extending preservation time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OrganOx company profile →
Verici Dx
HQ: United States
Website
- Description: Provider of RNA signature-based diagnostics for kidney transplant patients, offering pre- and post-transplant prognostic tests—Clarava to predict early rejection risk and Tutivia to assess post-transplant rejection risk—and RNA Signature Tests that provide insights into immune response and transplant prognosis, while tracking patient records and the patient journey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verici Dx company profile →
CareDx
HQ: United States
Website
- Description: Provider of transplant care solutions, including non-invasive diagnostics (AlloSure for kidney and AlloMap for heart), remote patient monitoring (AlloHome), pharmacy services managing immunosuppressants and maintenance drugs (The Transplant Pharmacy), and software for organ and cellular transplant program management (Ottr Organ and Ottr Cellular).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CareDx company profile →
XVIVO
HQ: Sweden
Website
- Description: Provider of organ perfusion, preservation, and assessment solutions for transplantation, including XPS for ex vivo lung perfusion and assessment; Liver Assist for hypothermic, normothermic, and sub-normothermic liver preservation; Kidney Assist Transport for hypothermic pulsatile perfusion of donor kidneys up to 24 hours; PERFADEX Plus for static cold storage of lungs; STEEN Solution for lung assessment; and XVIVO Academy training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XVIVO company profile →
SQI Diagnostics
HQ: Canada
Website
- Description: Provider of medical systems and diagnostics leveraging proprietary multiplexing, miniaturization, and automation; offerings include RALI-Dx IL-6 Severity Triage for COVID-19, rapid mobile PCR testing, Sofia SARS Antigen FIA, Sofia2 Flu+SARS Antigen FIA, QuickVue At-Home OTC COVID-19 test, and the TORdx LUNG test under development to assess donor lung health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SQI Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Essential Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Essential Pharma
2.2 - Growth funds investing in similar companies to Essential Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Essential Pharma
4.2 - Public trading comparable groups for Essential Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →